Yellow scene tap barring entrance to treatment.
·
6 Min Read

Key to opioid progress: Make insurers comply on treatment access

Lack of transparency and complaint-driven enforcement hinder coverage parity for substance-use disorder treatment, says a recent analysis.

Behavioral Health
·
2 Min Read

AMA statement on new CDC study showing decline in opioid prescribing

Statement from Patrice A. Harris, M.D., MA, chair of the AMA Opioid Task Force, on a new CDC report issued today

Press Releases
Mary Anne McCaffree, MD
·
6 Min Read

Women bear greater burden of opioid epidemic

While treatment for opioid-use disorder remains gender blind, the impact and effects of the disease are not.

Behavioral Health
·
5 Min Read

June 29, 2017: State Advocacy Update

Nevada governor vetoes balance-billing legislation and AMA's opioid microsite in the latest state and local advocacy efforts.

Advocacy Update
·
3 Min Read

Physicians call for better prescription drug-monitoring programs

Use of state prescription drug monitoring programs has grown significantly, but gaps remain—including a lack of data from VA pharmacies.

Behavioral Health
·
2 Min Read

June 16, 2017: Advocacy spotlight on AMA launches opioid education microsite

With nearly 300 resources, AMA's new microsite seeks to continue fighting the opioid epidemic.

Advocacy Update
Doctor speaks to crowd on pain care.
·
3 Min Read

Pain care and opioid-use disorder are focus of new efforts

While reversing the opioid epidemic remains a vital focus, AMA delegates seek strategies, education to help the millions who live with chronic pain.

Behavioral Health
Physicians standing in line to have their voices heard at meeting.
·
4 Min Read

Physicians recognize new psychoactive substances as health threat

Legal synthetic drugs such as Spice are quickly emerging and difficult to track. The AMA wants new strategies and education on these new drugs of abuse.

Behavioral Health
·
4 Min Read

AMA wants new approaches to combat synthetic and injectable drugs

The AMA today voted to support an to close a gap in the nation’s ability to identify, regulate, and mitigate the dangers posed by new psychoactive substances

Press Releases